Abstract
Eosinophils are granular leukocytes known to have a central role in the effector arm of Th2 immune responses elicited in allergic diseases and parasitic inflammation. Macrophage migration inhibitory factor (MIF), a proinflammatory cytokine that not only contributes to the immune response to infection but also promotes tissue damage in sterile inflammation, and infectious conditions, is important in Th2 immune responses. Activated Th2 cells have increased MIF mRNA and protein, while eosinophils have mRNA and the preformed protein and secrete high quantities of MIF upon stimulation. In animal models of eosinophilic inflammation such as asthma, rhinitis, dermatitis, eosinophilic esophagitis, and helminth infection, the blockage or the genetic lack of MIF causes a significant reduction of the cardinal signs observed in these diseases. Importantly, atopic patients have increased MIF in affected tissues. MIF also affects several aspects of eosinophil physiology including differentiation, survival, activation, and migration. In this chapter, we reviewed the current knowledge of the role of MIF in eosinophil biology and in eosinophilic inflammatory conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Sanderson CJ (1992) Interleukin-5, eosinophils, and disease. Blood 79(12):3101–3109
Spencer LA et al (2014) Eosinophil secretion of granule-derived cytokines. Front Immunol 5:496
Neves JS, Weller PF (2009) Functional extracellular eosinophil granules: novel implications in eosinophil immunobiology. Curr Opin Immunol 21(6):694–699
Williams TJ (2004) The eosinophil enigma. J Clin Invest 113(4):507–509
Shimizu T et al (1997) Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis. Biochem Biophys Res Commun 240(1):173–178
Shimizu T et al (1999) Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis. J Allergy Clin Immunol 104(3 Pt 1):659–664
Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN, Bucala R, Donnelly SC (1998) Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Investig 101:2869–2874
Yamaguchi E et al (2000) Macrophage migration inhibitory factor (MIF) in bronchial asthma. Clin Exp Allergy 30(9):1244–1249
Calandra T et al (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179(6):1895–1902
Bacher M et al (1996) An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 93(15):7849–7854
Makita H et al (1998) Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med 158(2):573–579
Wang B et al (2006) Cutting edge: deficiency of macrophage migration inhibitory factor impairs murine airway allergic responses. J Immunol 177(9):5779–5784
Hizawa N et al (2004) Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Respir Crit Care Med 169(9):1014–1018
Mizue Y et al (2005) Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci U S A 102(40):14410–14415
Wu J et al (2009) Association of MIF promoter polymorphisms with childhood asthma in a northeastern Chinese population. Tissue Antigens 73(4):302–306
Kobayashi M et al (2006) Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats. Eur Respir J 27(4):726–734
Magalhaes ES et al (2007) Macrophage migration inhibitory factor is essential for allergic asthma but not for Th2 differentiation. Eur J Immunol 37(4):1097–1106
Chen PF et al (2010) ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma. Mol Med 16(9–10):400–408
Das R et al (2011) Role of macrophage migration inhibitory factor in the Th2 immune response to epicutaneous sensitization. J Clin Immunol 31(4):666–680
Amano T, Nishihira J, Miki I (2007) Blockade of macrophage migration inhibitory factor (MIF) prevents the antigen-induced response in a murine model of allergic airway inflammation. Inflamm Res 56(1):24–31
Torii M et al (2010) Thioredoxin suppresses airway inflammation independently of systemic Th1/Th2 immune modulation. Eur J Immunol 40(3):787–796
Son A et al (2009) Direct association of thioredoxin-1 (TRX) with macrophage migration inhibitory factor (MIF): regulatory role of TRX on MIF internalization and signaling. Antioxid Redox Signal 11(10):2595–2605
Kleemann R et al (1999) Characterization of catalytic centre mutants of macrophage migration inhibitory factor (MIF) and comparison to Cys81Ser MIF. Eur J Biochem 261(3):753–766
Potolicchio I, Santambrogio L, Strominger JL (2003) Molecular interaction and enzymatic activity of macrophage migration inhibitory factor with immunorelevant peptides. J Biol Chem 278(33):30889–30895
Thiele M, Bernhagen J (2005) Link between macrophage migration inhibitory factor and cellular redox regulation. Antioxid Redox Signal 7(9–10):1234–1248
Vieira-de-Abreu A1, Calheiros AS, Mesquita-Santos FP, Magalhães ES, Mourão-Sá D, Castro-Faria-Neto HC, Bozza MT, Bandeira-Melo C, Bozza PT (2011) Crosstalk between macrophage migration inhibitory factor and eotaxin in allergic eosinophil activation forms leukotriene C4-synthesizing lipid bodies. Am J Respir Cell Mol Biol 44(4):509–16. doi: 10.1165/rcmb.2010-0004OC. Epub 2010 Jun 10
Saglani S, Lloyd CM (2015) Novel concepts in airway inflammation and remodelling in asthma. Eur Respir J 46(6):1796–1804
Humbles AA et al (2004) A critical role for eosinophils in allergic airways remodeling. Science 305(5691):1776–1779
Fattouh R et al (2011) Eosinophils are dispensable for allergic remodeling and immunity in a model of house dust mite-induced airway disease. Am J Respir Crit Care Med 183(2):179–188
Gregory LG, Lloyd CM (2011) Orchestrating house dust mite-associated allergy in the lung. Trends Immunol 32(9):402–411
Lambrecht BN, Hammad H (2015) The immunology of asthma. Nat Immunol 16(1):45–56
Nakamaru Y et al (2004) Macrophage migration inhibitory factor in allergic rhinitis: its identification in eosinophils at the site of inflammation. Ann Otol Rhinol Laryngol 113(3 Pt 1):205–209
Nakamaru Y et al (2005) Macrophage migration inhibitory factor (MIF) contributes to the development of allergic rhinitis. Cytokine 31(2):103–108
Weidinger S, Novak N (2016) Atopic dermatitis. Lancet 387(10023):1109–1122
Yawalkar N et al (1999) Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 113(1):43–48
Shimizu T (2005) Role of macrophage migration inhibitory factor (MIF) in the skin. J Dermatol Sci 37(2):65–73
Yoshihisa Y et al (2011) Macrophage migration inhibitory factor is essential for eosinophil recruitment in allergen-induced skin inflammation. J Invest Dermatol 131(4):925–931
Hamasaka A et al (2009) DNA vaccination against macrophage migration inhibitory factor improves atopic dermatitis in murine models. J Allergy Clin Immunol 124(1):90–99
Nagata Y et al (2015) Role of macrophage migration inhibitory factor (MIF) in pollen-induced allergic conjunctivitis and pollen dermatitis in mice. PLoS One 10(2):e0115593
Chehade M et al (2007) Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 45(3):319–328
Li-Kim-Moy JP et al (2011) Esophageal subepithelial fibrosis and hyalinization are features of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 52(2):147–153
de Souza HS et al (2015) Macrophage migration inhibitory factor promotes eosinophil accumulation and tissue remodeling in eosinophilic esophagitis. Mucosal Immunol 8(5):1154–1165
Rieder F et al (2007) Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Gastroenterology 132(1):154–165
Bernhagen J et al (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13(5):587–596
Pawig L et al (2015) Diversity and inter-connections in the CXCR4 chemokine receptor/ligand family: molecular perspectives. Front Immunol 6:429
Nagase H et al (2000) Expression of CXCR4 in eosinophils: functional analyses and cytokine-mediated regulation. J Immunol 164(11):5935–5943
Iikura M et al (2001) Chemokine receptors in human basophils: inducible expression of functional CXCR4. J Leukoc Biol 70(1):113–120
Blanchard C, Rothenberg ME (2008) Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 18(1):133–143; x
Noti M et al (2013) Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med 19(8):1005–1013
McDermott DH et al (2014) A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood 123(15):2308–2316
Stavitsky AB et al (2003) Blockade of macrophage migration inhibitory factor (MIF) in Schistosoma japonicum-infected mice results in an increased adult worm burden and reduced fecundity. Parasite Immunol 25(7):369–374
Reiman RM et al (2006) Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun 74(3):1471–1479
Fallon PG et al (2000) Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 164(5):2585–2591
Rodriguez-Sosa M et al (2003) Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps. Infect Immun 71(3):1247–1254
Magalhaes ES et al (2009) Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection. FASEB J 23(4):1262–1271
David JR, Butterworth AE, Vadas MA (1980) Mechanism of the interaction mediating killing of Schistosoma mansoni by human eosinophils. Am J Trop Med Hyg 29(5):842–848
Davies SJ et al (2005) In vivo imaging of tissue eosinophilia and eosinopoietic responses to schistosome worms and eggs. Int J Parasitol 35(8):851–859
Swartz JM et al (2006) Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood 108(7):2420–2427
Damle SR et al (2017) Macrophage migration inhibitory factor deficiency enhances immune response to Nippostrongylus brasiliensis. Mucosal Immunol 10(1):205–214
Pastrana DV et al (1998) Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect Immun 66(12):5955–5963
Falcone FH et al (2001) A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection. J Immunol 167(9):5348–5354
Zang X et al (2002) Homologues of human macrophage migration inhibitory factor from a parasitic nematode. Gene cloning, protein activity, and crystal structure. J Biol Chem 277(46):44261–44267
Prieto-Lafuente L et al (2009) MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages. J Leukoc Biol 85(5):844–854
Younis AE et al (2012) Characterization of a secreted macrophage migration inhibitory factor homologue of the parasitic nematode Strongyloides acting at the parasite-host cell interface. Microbes Infect 14(3):279–289
Park SK et al (2009) Macrophage migration inhibitory factor homologs of anisakis simplex suppress Th2 response in allergic airway inflammation model via CD4+CD25+Foxp3+ T cell recruitment. J Immunol 182(11):6907–6914
Cho MK, Lee CH, Yu HS (2011) Amelioration of intestinal colitis by macrophage migration inhibitory factor isolated from intestinal parasites through toll-like receptor 2. Parasite Immunol 33(5):265–275
Cho MK et al (2015) TLR2-dependent amelioration of allergic airway inflammation by parasitic nematode type II MIF in mice. Parasite Immunol 37(4):180–191
Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3(10):791–800
Rossi RE, Monasterolo G, Operti D (1998) A comparative study of the tryptase release test and the cellular allergen stimulation test (CAST) in mite sensitive patients. Clin Exp Allergy 28(6):752–757
Souza AL et al (2005) Potential role of the chemokine macrophage inflammatory protein 1alpha in human and experimental schistosomiasis. Infect Immun 73(4):2515–2523
Vieira-de-Abreu A et al (2011) Cross-talk between macrophage migration inhibitory factor and eotaxin in allergic eosinophil activation forms leukotriene C(4)-synthesizing lipid bodies. Am J Respir Cell Mol Biol 44(4):509–516
Rothenberg ME, Hogan SP (2006) The eosinophil. Annu Rev Immunol 24:147–174
Baumann R et al (2003) Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J 17(15):2221–2230
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Bozza, M.T., Paiva, C.N., Olsen, P.C. (2017). MIF in Eosinophilic Inflammation. In: Bucala, R., Bernhagen, J. (eds) MIF Family Cytokines in Innate Immunity and Homeostasis. Progress in Inflammation Research. Springer, Cham. https://doi.org/10.1007/978-3-319-52354-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-52354-5_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52352-1
Online ISBN: 978-3-319-52354-5
eBook Packages: MedicineMedicine (R0)